Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

9.75
+0.06000.62%
Pre-market: 9.72-0.0300-0.31%04:37 EDT
Volume:11.78M
Turnover:114.52M
Market Cap:10.33B
PE:-9.86
High:9.93
Open:9.50
Low:9.33
Close:9.69
52wk High:12.43
52wk Low:1.95
Shares:1.06B
Float Shares:407.00M
Volume Ratio:0.56
T/O Rate:2.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9887
EPS(LYR):-0.3820
ROE:78.05%
ROA:-30.54%
PB:-9.87
PE(LYR):-25.52

Loading ...

ImmunityBio Director Cheryl Cohen Reports Disposal of Common Shares Worth $851,088

Reuters
·
Yesterday

Movement Alert|ImmunityBio, Inc. Falls 5.15% in Regular Trading, Biotechnology Sector Weakens Broadly

Market Focus
·
Oct 06

Movement Alert|ImmunityBio, Inc. Rises 5.69% in Pre-Market Trading, Trading at $10.87

Market Focus
·
Oct 05

Immunitybio Inc Stock (IBRX) Moved Up by 9.64% on Oct 2: What Investors Need To Know

TradingKey
·
Oct 03

ImmunityBio call volume above normal and directionally bullish

TIPRANKS
·
Oct 02

ImmunityBio Attends Thoracic Rare Cancer Symposium Thoracs

Reuters
·
Oct 02

ImmunityBio rises 11.6%

TIPRANKS
·
Oct 02

Movement Alert|ImmunityBio, Inc. Rises 10.13% in Regular Trading, Trading at $10.2101

Market Focus
·
Oct 02

HLS Therapeutics Appoints Linda Maxwell, Mark DeLong as Independent Directors

Reuters
·
Oct 01

Immunitybio Inc Stock (IBRX) Moved Up by 11.15% on Sep 30: What Signal Does It Send?

TradingKey
·
Oct 01

ImmunityBio rises 12.3%

TIPRANKS
·
Oct 01

ImmunityBio’s New Sepsis Trial: Early-Stage Data With High-Stakes Market Potential

TIPRANKS
·
Sep 26

ImmunityBio call volume above normal and directionally bullish

TIPRANKS
·
Sep 23

PDS Biotech Adds Patrick Soon-Shiong, NantBio CFO James Banaag to Board

Reuters
·
Sep 14

PDS Biotech Announces Initial Closing of up to $22.3 Million Pipe Financing and the Appointment of DR. Patrick Soon-Shiong to Its Board of Directors

THOMSON REUTERS
·
Sep 14

ImmunityBio put volume heavy and directionally bearish

TIPRANKS
·
Sep 10

Does ImmunityBio’s (IBRX) Jim Yong Kim Hire Transform Its Global Access Strategy For Immunotherapies?

Simply Wall St.
·
Aug 25

Does Adding Jim Yong Kim to Leadership Shift ImmunityBio’s Global Strategy Narrative (IBRX)?

Simply Wall St.
·
Aug 15

ImmunityBio Names Former World Bank Chief Jim Yong Kim Vice Chairman

Reuters
·
Aug 10

Immunitybio Appoints DR. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman

THOMSON REUTERS
·
Aug 10